Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Jounce Therapeutics
Work at Jounce Therapeutics?
Add yourself to this profile
2936
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immunesystem to attack cancerous cells and tumors.
Edit Profile
jouncetx.com
Technology
>
Biotechnology
B2c
Founded in
2013
Raised
$158M
More info
Elsewhere
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
HubSpot
nuTonomy
Biogen
General Catalyst
Harvard University
Companies in the same industry
Mast Therapeutics, Inc.
BioCision
Diomics
Vasopharm
Cofactor Genomics
Cariloop
GlassesOff
InPulse Medical
Molecular Imaging
Izun Pharmaceuticals
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
IPO
$102,000,000
Venture capital (Series B)
$56,000,000
Redmile Group
,
Foresite Capital
,
Wellington Management
, +5
Employees
Team size
50+
Locations
HQ
Cambridge
,
United States
Headquarters
$102,000,000
IPO
Xconomy
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17
Stock markets
Earnings
$56,000,000
Venture capital (Series B)
VentureWire
The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot
Funding
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
HubSpot
nuTonomy
Biogen
General Catalyst
Harvard University
Mast Therapeutics, Inc.
BioCision
Diomics
Cofactor Genomics
Cariloop
Molecular Imaging
Izun Pharmaceuticals